# Low-Dose Dobutamine Tc-99m-Mibi Gated SPECT to Predict Left Ventricular Remodelling in Patients Reperfused in the Acute Phase of MI

> **NCT00487812** · NA · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 50 (estimated)

## Conditions studied

- Ischemic Heart Disease
- Myocardial Infarction

## Interventions

- **PROCEDURE:** Low-dose dobutamine Tc-99-m-mibi gated SPECT imaging

## Key facts

- **NCT ID:** NCT00487812
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2006-08
- **Final completion:** 2008-09
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2008-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00487812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00487812, "Low-Dose Dobutamine Tc-99m-Mibi Gated SPECT to Predict Left Ventricular Remodelling in Patients Reperfused in the Acute Phase of MI". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00487812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*